Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
B-ENT ; 10(2): 149-55, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25090814

RESUMEN

BACKGROUND: Oncogenic osteomalacia (OOM) is a rare paraneoplastic syndrome characterized by hypophosphatemia and overexpression of a phosphaturic agent, fibroblast growth factor 23 (FGF23). OOM is associated with a variety of mesenchymal tumours referred to as phosphaturic mesenchymal tumours. Head and neck regions are concerned in 5-10% of cases. METHODS AND RESULTS: We report the case of a 42-year-old female with OOM caused by a hemangiopericytoma of the left ethmoid sinus. The period between first symptoms and surgical excision of the lesion was approximately 5 years. We also conducted a PubMed-based search to identify all cases of OOM related to sinonasal tumour. Twenty eight cases in the sinonasal area were reported in the literature. CONCLUSION: OOM is an important diagnosis because resection of the causative tumour results in cure of the disease.


Asunto(s)
Senos Etmoidales , Hemangiopericitoma/complicaciones , Neoplasias de Tejido Conjuntivo/etiología , Neoplasias de los Senos Paranasales/complicaciones , Síndromes Paraneoplásicos/complicaciones , Adulto , Femenino , Factor-23 de Crecimiento de Fibroblastos , Humanos , Osteomalacia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...